ESR1 and breast carcinoma: The majority of breast cancer tumors were ductal (86.9%), single focus (84.2%), breast carcinoma stage I (65%), tumor classification T1c (40.4%), lymph node negative (77.5%), ER positive (98.8%), PR positive (87.8%), and HER2 negative (91.2%).